Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Batard

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Cytotechnology|November 13, 2008
S-phase synchronized CHO cells show elevated transfection efficiency and expression using CaPiFrédéric Grosjean, Pascal Batard, Martin Jordan, et al.
Biotechnology and Bioengineering|January 15, 2002
Fluorescent proteins in animal cells for process development: optimization of sodium butyrate treatment as an exampleLisa Hunt, Pascal Batard, Martin Jordan, et al.
Cytometry|July 13, 2002
Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitationsPascal Batard, Janos Szollosi, Immanuel Luescher, et al.
Cancer Immunity|September 10, 2003
Disease-driven T cell activation predicts immune responses to vaccination against melanomaDaniel E Speiser, Donata Rimoldi, Pascal Batard, et al.
European Journal of Immunology|March 1, 2002
In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cellsDaniel E Speiser, Danielle Liénard, Mikaël J Pittet, et al.
Journal of Immunological Methods|March 7, 2006
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cellsPascal Batard, Daniel A Peterson, Estelle Devêvre, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cellsMikaël J Pittet, Verena Rubio-Godoy, Gilles Bioley, et al.
Blood|May 17, 2003
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functionsNathalie Rufer, Alfred Zippelius, Pascal Batard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCRValérie Dutoit, Verena Rubio-Godoy, Marie-Agnès Doucey, et al.
The Journal of Experimental Medicine|February 21, 2002
Thymic selection generates a large T cell pool recognizing a self-peptide in humansAlfred Zippelius, Mikaël J Pittet, Pascal Batard, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Cytotechnology|November 13, 2008
S-phase synchronized CHO cells show elevated transfection efficiency and expression using CaPiFrédéric Grosjean, Pascal Batard, Martin Jordan, et al.
Biotechnology and Bioengineering|January 15, 2002
Fluorescent proteins in animal cells for process development: optimization of sodium butyrate treatment as an exampleLisa Hunt, Pascal Batard, Martin Jordan, et al.
Cytometry|July 13, 2002
Use of phycoerythrin and allophycocyanin for fluorescence resonance energy transfer analyzed by flow cytometry: advantages and limitationsPascal Batard, Janos Szollosi, Immanuel Luescher, et al.
Cancer Immunity|September 10, 2003
Disease-driven T cell activation predicts immune responses to vaccination against melanomaDaniel E Speiser, Donata Rimoldi, Pascal Batard, et al.
European Journal of Immunology|March 1, 2002
In vivo activation of melanoma-specific CD8(+) T cells by endogenous tumor antigen and peptide vaccines. A comparison to virus-specific T cellsDaniel E Speiser, Danielle Liénard, Mikaël J Pittet, et al.
Journal of Immunological Methods|March 7, 2006
Dextramers: new generation of fluorescent MHC class I/peptide multimers for visualization of antigen-specific CD8+ T cellsPascal Batard, Daniel A Peterson, Estelle Devêvre, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Alpha 3 domain mutants of peptide/MHC class I multimers allow the selective isolation of high avidity tumor-reactive CD8 T cellsMikaël J Pittet, Verena Rubio-Godoy, Gilles Bioley, et al.
Blood|May 17, 2003
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functionsNathalie Rufer, Alfred Zippelius, Pascal Batard, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2002
Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCRValérie Dutoit, Verena Rubio-Godoy, Marie-Agnès Doucey, et al.
The Journal of Experimental Medicine|February 21, 2002
Thymic selection generates a large T cell pool recognizing a self-peptide in humansAlfred Zippelius, Mikaël J Pittet, Pascal Batard, et al.
Pageof 2